Atea Projects Over $700M Annual U.S. HCV Revenue Potential
Atea Pharmaceuticals (AVIR) outlined peak annual U.S. net revenue potential exceeding $700 million, driven by its mid-2028 hepatitis C (HCV) launch. This...

Atea Pharmaceuticals (AVIR) outlined peak annual U.S. net revenue potential exceeding $700 million, driven by its mid-2028 hepatitis C (HCV) launch. This...

Global Water Resources, Inc. announced strong second quarter 2026 results, with total revenue climbing 24.8% to $17.8 million and net income rising...

Sera Prognostics aims for 1-2% Illinois Medicaid penetration by 2027 and 5-7 new commercial programs, following Q2 2026 wins including new partnerships...

Sezzle President Paul Paradis disposed of 7,110 shares for tax obligations, a non-discretionary move. He retains a $144.6 million stake, signaling confidence.

First Majestic Silver Corp (AG) shares surged on Tuesday, crossing above their 200-day moving average of $6.08 and trading up 10.5% on...

As of August 10, 2026, Nvidia's $5.3 trillion market capitalization prompts debate among analysts regarding its investment viability. Despite strong financials, concerns...

Insight Molecular Diagnostics (IMDX) will report Q2 2026 earnings on August 10th. Analysts forecast -$0.25 EPS and $0.44M revenue, noting past EPS...

The Shanghai Composite Index has advanced for four consecutive sessions, gaining 3.5%, and is set to extend its winning streak on Monday...

Investors are set for a busy start to the week with several prominent companies, including Barrick Mining and monday.com, slated to release...